Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy

International Journal of Clinical Pharmacology Research

Volumn 19, Issue 3, 1999, Pages 65-71

  Yew, W W ^a   Cheung, S W ^b   Chau, C H ^a   Chan, C Y ^b   Leung, C K ^a   Cheng, A F B ^b   Wong, C F ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIMYCOBACTERIAL AGENT; CYCLOSERINE; ETHAMBUTOL; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAS CHROMATOGRAPHY; GAS LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; TUBERCULOSIS;

ADULT; AMIKACIN; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; KANAMYCIN; MALE; MIDDLE AGED; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0033503947     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Goble M., Iseman M.D., Madsen L.A., Waite D., Ackerson L., Horsburg C.R. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med., 328, 527, 1993.
2. Park M.M., Davis A.L., Schluger N.W., Cohen H., Rom W.N. Outcome of MDR-TB patients 1983-1993: Prolonged survival with appropriate therapy. Am. J. Resp. Crit. Care Med., 153, 317, 1996.
3. Chaulet P., Raviglione M., Bustreo F. Epidemiology, control and treatment of multidrug-resistant tuberculosis. Drugs, 52 (Suppl. 2), 103, 1996.
4. Crofton J., Chaulet P., Maher D. "Guidelines for the management of drug-resistant tuberculosis". World Health Organization, Geneva, 1997.
5. Peloquin C.A. Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin. Chest Med., 18, 79, 1997.
6. Yew W.W. Therapeutic drug monitoring in antituberculosis chemotherapy. Ther. Drug Monit., 20, 469, 1998.
7. Abbott Laboratories. "System Assays", Abbott, USA, 1990.
8. Chan C.Y., Lam A.W., French G.L. Rapid HPLC assay of fluoroquinolones in clinical specimens. J. Antimicrob. Chemother., 23, 597, 1989.
9. Lyon D.J., Cheung S.W., Chan C.Y., Cheng A.F.B. Rapid HPLC assay of clinafloxacin, fleroxacin, levofloxacin, sparfloxacin and tosufloxacin. J. Antimicrob. Chemother., 34, 446, 1994.
10. De Vos M., Verdievel H., Schoonjans R., Beke R., De Weerdt G.A., Barbier F. High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans. J. Antimicrob. Chemother., 564, 296, 1991.
11. Peloquin C.A. Improved high-performance liquid chromatographic assay for the determination of ethionamide in serum. J. Chromatogr., 563, 472, 1991.
12. Musson D.G., Maglietto S.M., Hwang S.S., Gravellese D., Bayne W.F. Simultaneous quantification of cycloserine and its pro-drug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization. J. Chromatogr., 414, 121, 1987.
13. Chan K. A systematic approach for the simultaneous assay of some anti-tuberculous drugs in CSF and plasma by liquid chromatography. J. Liq. Chromatogr., 11, 1051, 1988.
14. Lee C.S., Wang L.H. Improved GLC determination of ethambutol. J. Pharm. Sci., 69, 362, 1980.
15. Iseman M.D. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med., 329, 784, 1993.
16. Patel A.M., McKeon J. Avoidance and management of adverse reactions to antituberculosis drugs. Drug Safety, 12, 1, 1995.
17. Yew W.W., Piddock L.J.V., Li M.S.K., Lyon D., Chan C.Y., Cheng A.F.B. In vitro activity of quinolones and macrolides against mycobacteria. J. Antimicrob. Chemother., 34, 343, 1994.
18. Todd P.A., Faulds D. Ofloxacin: A reappraisal of its antimicrobial activity, pharmacology and therapeutic use. Drugs, 42, 825, 1991.
19. Davis R., Bryson H.M. Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47, 677, 1994.